

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.58031262 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.33494702 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.33494702 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.99594273 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.57010813 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.52460737 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.24352463 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.24352463 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 5.24352463 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.24352463 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 5.24352463 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.24352463 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.07686656 |
| 14 | negative regulation of cell killing (GO:0031342) | 5.07686656 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.96530501 |
| 16 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.89592025 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.72210935 |
| 18 | positive thymic T cell selection (GO:0045059) | 4.64103745 |
| 19 | negative thymic T cell selection (GO:0045060) | 4.62956808 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.62772714 |
| 21 | negative T cell selection (GO:0043383) | 4.62245586 |
| 22 | B cell receptor signaling pathway (GO:0050853) | 4.27376163 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.17094297 |
| 24 | leukocyte aggregation (GO:0070486) | 4.14250603 |
| 25 | T cell migration (GO:0072678) | 4.08183570 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 4.05783292 |
| 27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.01892749 |
| 28 | regulation of B cell differentiation (GO:0045577) | 4.01415694 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 4.00407394 |
| 30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.98419824 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.97857959 |
| 32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.96386446 |
| 33 | thymic T cell selection (GO:0045061) | 3.95101603 |
| 34 | response to interleukin-15 (GO:0070672) | 3.90687486 |
| 35 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.90617366 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.85618374 |
| 37 | positive T cell selection (GO:0043368) | 3.83769056 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.82301775 |
| 39 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.78730049 |
| 40 | T cell selection (GO:0045058) | 3.75641566 |
| 41 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.70643596 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.70459070 |
| 43 | interferon-gamma production (GO:0032609) | 3.68405973 |
| 44 | cellular response to interleukin-15 (GO:0071350) | 3.67793549 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.66340064 |
| 46 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.64419206 |
| 47 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.64419206 |
| 48 | tolerance induction (GO:0002507) | 3.61908901 |
| 49 | positive regulation of granulocyte differentiation (GO:0030854) | 3.59545198 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.57744712 |
| 51 | response to type I interferon (GO:0034340) | 3.57254891 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 3.54591619 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.53855442 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.53855442 |
| 55 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.52021651 |
| 56 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.51559781 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48558558 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.44232114 |
| 59 | respiratory burst (GO:0045730) | 3.41544254 |
| 60 | regulation of cell killing (GO:0031341) | 3.40043123 |
| 61 | mast cell activation involved in immune response (GO:0002279) | 3.36860247 |
| 62 | mast cell degranulation (GO:0043303) | 3.36860247 |
| 63 | positive regulation of defense response to virus by host (GO:0002230) | 3.35866356 |
| 64 | response to host immune response (GO:0052572) | 3.35611535 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.35611535 |
| 66 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.35145429 |
| 67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34634926 |
| 68 | NIK/NF-kappaB signaling (GO:0038061) | 3.31670248 |
| 69 | T cell costimulation (GO:0031295) | 3.30654012 |
| 70 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.29425774 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 3.29245238 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27586271 |
| 73 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.25605818 |
| 74 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.25100892 |
| 75 | lymphocyte costimulation (GO:0031294) | 3.23918593 |
| 76 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.23797157 |
| 77 | regulation of regulatory T cell differentiation (GO:0045589) | 3.23274025 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21613020 |
| 79 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.21332683 |
| 80 | leukocyte cell-cell adhesion (GO:0007159) | 3.20272999 |
| 81 | positive regulation of cell killing (GO:0031343) | 3.19406652 |
| 82 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.19324744 |
| 83 | myeloid cell activation involved in immune response (GO:0002275) | 3.18927514 |
| 84 | B cell mediated immunity (GO:0019724) | 3.18389968 |
| 85 | mast cell activation (GO:0045576) | 3.17428363 |
| 86 | positive regulation of isotype switching (GO:0045830) | 3.16688989 |
| 87 | defense response to protozoan (GO:0042832) | 3.16470328 |
| 88 | activated T cell proliferation (GO:0050798) | 3.15950537 |
| 89 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.15761223 |
| 90 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.15515146 |
| 91 | response to host (GO:0075136) | 3.15515146 |
| 92 | response to host defenses (GO:0052200) | 3.15515146 |
| 93 | regulation of germinal center formation (GO:0002634) | 3.15411431 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 3.14349550 |
| 95 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.12998659 |
| 96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.12959553 |
| 97 | T cell receptor signaling pathway (GO:0050852) | 3.11923177 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 3.09773942 |
| 99 | positive regulation of interferon-beta production (GO:0032728) | 3.05631916 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04478194 |
| 101 | neutrophil activation (GO:0042119) | 3.03374010 |
| 102 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03250171 |
| 103 | response to protozoan (GO:0001562) | 3.01966814 |
| 104 | B cell proliferation (GO:0042100) | 3.01168872 |
| 105 | lymph node development (GO:0048535) | 3.01014476 |
| 106 | regulation of response to interferon-gamma (GO:0060330) | 2.99136752 |
| 107 | regulation of T cell mediated immunity (GO:0002709) | 2.97936676 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.96787708 |
| 109 | granulocyte activation (GO:0036230) | 2.95763200 |
| 110 | leukocyte degranulation (GO:0043299) | 2.95309739 |
| 111 | natural killer cell mediated immunity (GO:0002228) | 2.95278498 |
| 112 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.95278498 |
| 113 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.95187933 |
| 114 | negative regulation of phagocytosis (GO:0050765) | 2.94895867 |
| 115 | detection of bacterium (GO:0016045) | 2.94736636 |
| 116 | negative regulation of interleukin-12 production (GO:0032695) | 2.94041428 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.92902411 |
| 118 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.92527314 |
| 119 | Peyers patch development (GO:0048541) | 2.92527314 |
| 120 | negative regulation of adaptive immune response (GO:0002820) | 2.92451376 |
| 121 | mature B cell differentiation (GO:0002335) | 2.92433492 |
| 122 | germinal center formation (GO:0002467) | 2.89382787 |
| 123 | regulation of tolerance induction (GO:0002643) | 2.89226513 |
| 124 | positive regulation of interleukin-2 production (GO:0032743) | 2.88306034 |
| 125 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.88270959 |
| 126 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87501500 |
| 127 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87501500 |
| 128 | pinocytosis (GO:0006907) | 2.87445716 |
| 129 | B cell homeostasis (GO:0001782) | 2.86566870 |
| 130 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86508942 |
| 131 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86508942 |
| 132 | positive regulation of T cell mediated immunity (GO:0002711) | 2.86080386 |
| 133 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85362223 |
| 134 | positive regulation of humoral immune response (GO:0002922) | 2.84423508 |
| 135 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.84389409 |
| 136 | T cell proliferation (GO:0042098) | 2.82737755 |
| 137 | negative regulation of innate immune response (GO:0045824) | 2.82444211 |
| 138 | detection of other organism (GO:0098543) | 2.81805108 |
| 139 | dendritic cell chemotaxis (GO:0002407) | 2.80735107 |
| 140 | regulation of alpha-beta T cell activation (GO:0046634) | 2.80052079 |
| 141 | regulation of defense response to virus by host (GO:0050691) | 2.77747683 |
| 142 | dendritic cell migration (GO:0036336) | 2.77508684 |
| 143 | alpha-beta T cell differentiation (GO:0046632) | 2.76835327 |
| 144 | DNA deamination (GO:0045006) | 2.75998099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.78029347 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.18317805 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.88147019 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.34305086 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.09130028 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.50336632 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.45120286 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.40590434 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.23176579 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.15616489 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.13184820 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.07009118 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05076231 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01229430 |
| 15 | * MYC_22102868_ChIP-Seq_BL_Human | 2.97375625 |
| 16 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.89073892 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.85526089 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.61703799 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.61496890 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60448723 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59525376 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.59189433 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53350212 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.53118960 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29678277 |
| 26 | * MYB_26560356_Chip-Seq_TH1_Human | 2.29020405 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.18754558 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16228710 |
| 29 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.15169777 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.14310747 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.11650324 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.07333416 |
| 33 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04259977 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00210083 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98376043 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96903913 |
| 37 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84457915 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82940083 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81515866 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74808101 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71177861 |
| 42 | * MAF_26560356_Chip-Seq_TH2_Human | 1.66854346 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.66214975 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60297032 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59146096 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.57735705 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56727424 |
| 48 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.54555211 |
| 49 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48533754 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45972866 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44103565 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42208368 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.40399976 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38988511 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38542050 |
| 56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36746552 |
| 57 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34739330 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32699032 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31340448 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30155141 |
| 61 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.27397421 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27182267 |
| 63 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26241161 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24499683 |
| 65 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20794228 |
| 66 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19399912 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17368854 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15208871 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13690584 |
| 70 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10458797 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.09656935 |
| 72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08981323 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08736061 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08439539 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06312984 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06266934 |
| 77 | GATA3_26560356_Chip-Seq_TH1_Human | 1.06148845 |
| 78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05852166 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04971836 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04542797 |
| 81 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04125813 |
| 82 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03775568 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03670274 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02873264 |
| 85 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02101189 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01723887 |
| 87 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99390147 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.98623626 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97688720 |
| 90 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97355940 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.96025976 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95452315 |
| 93 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95415441 |
| 94 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95067943 |
| 95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93330333 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93273235 |
| 97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91883590 |
| 98 | P300_27268052_Chip-Seq_Bcells_Human | 0.91318309 |
| 99 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90269744 |
| 100 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90218074 |
| 101 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89896621 |
| 102 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89179247 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88386607 |
| 104 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.87851107 |
| 105 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87203539 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86542313 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86293545 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85827130 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85460215 |
| 110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85183396 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83952050 |
| 112 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.83722842 |
| 113 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81892566 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81752833 |
| 115 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81712423 |
| 116 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80716985 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79520919 |
| 118 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79081355 |
| 119 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.78634894 |
| 120 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.78360976 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.77584941 |
| 122 | * TP53_22573176_ChIP-Seq_HFKS_Human | 0.77536132 |
| 123 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.74910532 |
| 124 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74340520 |
| 125 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.74217715 |
| 126 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.74217715 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74209122 |
| 128 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.73400741 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72988664 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72838857 |
| 131 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71284378 |
| 132 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.69281133 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.67797238 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65873838 |
| 135 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.65617467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.49777041 |
| 2 | MP0005671_abnormal_response_to | 3.49056307 |
| 3 | MP0005387_immune_system_phenotype | 3.42806390 |
| 4 | MP0001790_abnormal_immune_system | 3.42806390 |
| 5 | MP0001800_abnormal_humoral_immune | 3.38014696 |
| 6 | MP0003303_peritoneal_inflammation | 3.35659603 |
| 7 | MP0000685_abnormal_immune_system | 3.33618821 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.19450789 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.99830426 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.99433255 |
| 11 | MP0003436_decreased_susceptibility_to | 2.97583165 |
| 12 | MP0006082_CNS_inflammation | 2.89242457 |
| 13 | MP0009785_altered_susceptibility_to | 2.86622811 |
| 14 | * MP0002723_abnormal_immune_serum | 2.85204040 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.77084630 |
| 16 | MP0001819_abnormal_immune_cell | 2.74753859 |
| 17 | MP0005025_abnormal_response_to | 2.69283621 |
| 18 | MP0002419_abnormal_innate_immunity | 2.65986769 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.59603993 |
| 20 | MP0002398_abnormal_bone_marrow | 2.43535093 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.36758589 |
| 22 | MP0002405_respiratory_system_inflammati | 2.29421828 |
| 23 | MP0000716_abnormal_immune_system | 2.28033389 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.27905014 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.18744197 |
| 26 | MP0004510_myositis | 2.12957318 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.12951277 |
| 28 | MP0003172_abnormal_lysosome_physiology | 2.11346433 |
| 29 | MP0005464_abnormal_platelet_physiology | 2.10913618 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 2.04170050 |
| 31 | MP0004947_skin_inflammation | 2.03432344 |
| 32 | MP0002722_abnormal_immune_system | 1.99236649 |
| 33 | MP0001873_stomach_inflammation | 1.92235948 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.89296874 |
| 35 | MP0002429_abnormal_blood_cell | 1.87599251 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.87192371 |
| 37 | MP0003724_increased_susceptibility_to | 1.85758567 |
| 38 | MP0002006_tumorigenesis | 1.81222949 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.76795906 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.72031657 |
| 41 | MP0005310_abnormal_salivary_gland | 1.67457311 |
| 42 | MP0001853_heart_inflammation | 1.66536713 |
| 43 | MP0002933_joint_inflammation | 1.51993313 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.51574634 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.47840051 |
| 46 | MP0003448_altered_tumor_morphology | 1.47698671 |
| 47 | MP0008469_abnormal_protein_level | 1.44613315 |
| 48 | MP0004381_abnormal_hair_follicle | 1.40752431 |
| 49 | MP0003866_abnormal_defecation | 1.40627732 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.36839520 |
| 51 | MP0003252_abnormal_bile_duct | 1.34198612 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.33178270 |
| 53 | MP0000858_altered_metastatic_potential | 1.32494180 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.30951711 |
| 55 | MP0010307_abnormal_tumor_latency | 1.27444348 |
| 56 | MP0009840_abnormal_foam_cell | 1.27320715 |
| 57 | MP0000604_amyloidosis | 1.25472601 |
| 58 | MP0009278_abnormal_bone_marrow | 1.24957058 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.24662224 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.23907004 |
| 61 | MP0003195_calcinosis | 1.22675448 |
| 62 | MP0003183_abnormal_peptide_metabolism | 1.17019344 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.13458741 |
| 64 | MP0001545_abnormal_hematopoietic_system | 1.12036769 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.12036769 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.09676181 |
| 67 | MP0003787_abnormal_imprinting | 1.07719385 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.05560901 |
| 69 | MP0000490_abnormal_crypts_of | 1.03658836 |
| 70 | MP0002009_preneoplasia | 0.98854141 |
| 71 | MP0001851_eye_inflammation | 0.98645353 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.95721902 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 0.93339302 |
| 74 | MP0003878_abnormal_ear_physiology | 0.93339302 |
| 75 | MP0009764_decreased_sensitivity_to | 0.93280512 |
| 76 | MP0002928_abnormal_bile_duct | 0.91865158 |
| 77 | MP0002019_abnormal_tumor_incidence | 0.85273967 |
| 78 | MP0005076_abnormal_cell_differentiation | 0.85118585 |
| 79 | MP0002163_abnormal_gland_morphology | 0.83816526 |
| 80 | MP0000343_altered_response_to | 0.83693759 |
| 81 | MP0000015_abnormal_ear_pigmentation | 0.82454921 |
| 82 | MP0002876_abnormal_thyroid_physiology | 0.80755371 |
| 83 | MP0002693_abnormal_pancreas_physiology | 0.79516561 |
| 84 | MP0009763_increased_sensitivity_to | 0.78856866 |
| 85 | MP0008872_abnormal_physiological_respon | 0.78530002 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 0.77708612 |
| 87 | MP0005166_decreased_susceptibility_to | 0.77593897 |
| 88 | MP0002102_abnormal_ear_morphology | 0.75455252 |
| 89 | MP0003646_muscle_fatigue | 0.75315407 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.73584300 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.72335341 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.70595130 |
| 93 | MP0002254_reproductive_system_inflammat | 0.67782074 |
| 94 | MP0003075_altered_response_to | 0.67682782 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.67107714 |
| 96 | MP0003091_abnormal_cell_migration | 0.65809901 |
| 97 | MP0003786_premature_aging | 0.65543857 |
| 98 | MP0001765_abnormal_ion_homeostasis | 0.65533025 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.65136154 |
| 100 | MP0001919_abnormal_reproductive_system | 0.64741756 |
| 101 | MP0003690_abnormal_glial_cell | 0.64357429 |
| 102 | MP0008057_abnormal_DNA_replication | 0.63657548 |
| 103 | MP0005023_abnormal_wound_healing | 0.63462822 |
| 104 | MP0004130_abnormal_muscle_cell | 0.61934143 |
| 105 | MP0003795_abnormal_bone_structure | 0.61650234 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.61523635 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.61307519 |
| 108 | MP0000609_abnormal_liver_physiology | 0.61271739 |
| 109 | MP0001663_abnormal_digestive_system | 0.61093387 |
| 110 | MP0000371_diluted_coat_color | 0.59718980 |
| 111 | MP0000249_abnormal_blood_vessel | 0.59380658 |
| 112 | MP0005379_endocrine/exocrine_gland_phen | 0.58282875 |
| 113 | MP0003828_pulmonary_edema | 0.57374364 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.57253482 |
| 115 | MP0005390_skeleton_phenotype | 0.57185334 |
| 116 | MP0004043_abnormal_pH_regulation | 0.56452680 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.56324526 |
| 118 | MP0003045_fibrosis | 0.55552236 |
| 119 | MP0003656_abnormal_erythrocyte_physiolo | 0.55181014 |
| 120 | MP0004142_abnormal_muscle_tone | 0.54567816 |
| 121 | MP0005083_abnormal_biliary_tract | 0.53372851 |
| 122 | MP0002138_abnormal_hepatobiliary_system | 0.52777321 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.52458511 |
| 124 | MP0008995_early_reproductive_senescence | 0.49986109 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.49306659 |
| 126 | MP0001348_abnormal_lacrimal_gland | 0.49063730 |
| 127 | MP0000598_abnormal_liver_morphology | 0.47845947 |
| 128 | MP0003077_abnormal_cell_cycle | 0.45801167 |
| 129 | MP0000313_abnormal_cell_death | 0.45450233 |
| 130 | MP0008873_increased_physiological_sensi | 0.44208258 |
| 131 | MP0005621_abnormal_cell_physiology | 0.42720724 |
| 132 | MP0002132_abnormal_respiratory_system | 0.42068514 |
| 133 | MP0009765_abnormal_xenobiotic_induced | 0.39695422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.50562215 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.14742402 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.70168227 |
| 4 | Chronic otitis media (HP:0000389) | 4.56458590 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.49915826 |
| 6 | Recurrent viral infections (HP:0004429) | 4.40205506 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.22900091 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.21089041 |
| 9 | T lymphocytopenia (HP:0005403) | 4.14379480 |
| 10 | Myositis (HP:0100614) | 4.12966464 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.04891524 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.04187104 |
| 13 | IgM deficiency (HP:0002850) | 3.88079927 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.85693803 |
| 15 | Stomatitis (HP:0010280) | 3.82755348 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.76658594 |
| 17 | Nasal polyposis (HP:0100582) | 3.76472735 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.66067212 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.63893377 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.55112787 |
| 21 | Recurrent skin infections (HP:0001581) | 3.53503496 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.53348281 |
| 23 | Obstructive lung disease (HP:0006536) | 3.53037094 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.53037094 |
| 25 | Vasculitis (HP:0002633) | 3.49604390 |
| 26 | Meningitis (HP:0001287) | 3.48530917 |
| 27 | Inflammation of the large intestine (HP:0002037) | 3.45381323 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44285128 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44285128 |
| 30 | Abnormality of T cells (HP:0002843) | 3.43449768 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39183862 |
| 32 | Panhypogammaglobulinemia (HP:0003139) | 3.37706598 |
| 33 | Pustule (HP:0200039) | 3.36576916 |
| 34 | Cellulitis (HP:0100658) | 3.34714677 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 3.33010806 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.28812493 |
| 37 | Stomach cancer (HP:0012126) | 3.23571203 |
| 38 | Abnormality of the nasal mucosa (HP:0000433) | 3.23505028 |
| 39 | Colitis (HP:0002583) | 3.23237497 |
| 40 | Orchitis (HP:0100796) | 3.21435210 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 3.21043668 |
| 42 | Optic neuritis (HP:0100653) | 3.21043668 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 3.10334144 |
| 44 | Lymphopenia (HP:0001888) | 3.08320981 |
| 45 | Abnormality of the prostate (HP:0008775) | 3.06196681 |
| 46 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.00258535 |
| 47 | Gastrointestinal stroma tumor (HP:0100723) | 2.98461230 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.87054108 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.85555355 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.85101972 |
| 51 | Gingivitis (HP:0000230) | 2.78630031 |
| 52 | Pulmonary infiltrates (HP:0002113) | 2.77820870 |
| 53 | Leukocytosis (HP:0001974) | 2.77367107 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.74502051 |
| 55 | IgG deficiency (HP:0004315) | 2.73108033 |
| 56 | Loss of speech (HP:0002371) | 2.72113390 |
| 57 | Severe combined immunodeficiency (HP:0004430) | 2.71340380 |
| 58 | Combined immunodeficiency (HP:0005387) | 2.70293503 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70042729 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70042729 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70042729 |
| 62 | Chronic sinusitis (HP:0011109) | 2.68153999 |
| 63 | Thyroiditis (HP:0100646) | 2.67728140 |
| 64 | Eosinophilia (HP:0001880) | 2.67600434 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.63828312 |
| 66 | Emphysema (HP:0002097) | 2.63695537 |
| 67 | Increased IgE level (HP:0003212) | 2.61270171 |
| 68 | Congenital stationary night blindness (HP:0007642) | 2.59254566 |
| 69 | Osteomyelitis (HP:0002754) | 2.53689661 |
| 70 | Encephalitis (HP:0002383) | 2.50634977 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.49427545 |
| 72 | Chronic diarrhea (HP:0002028) | 2.49408455 |
| 73 | Disinhibition (HP:0000734) | 2.49354331 |
| 74 | Papilloma (HP:0012740) | 2.49339637 |
| 75 | Verrucae (HP:0200043) | 2.49339637 |
| 76 | Periodontitis (HP:0000704) | 2.49320317 |
| 77 | Abnormality of eosinophils (HP:0001879) | 2.48942983 |
| 78 | Thrombocytosis (HP:0001894) | 2.47990955 |
| 79 | Arterial thrombosis (HP:0004420) | 2.45256482 |
| 80 | Prostate neoplasm (HP:0100787) | 2.43385533 |
| 81 | Abnormality of the fingertips (HP:0001211) | 2.43099729 |
| 82 | Hypochromic anemia (HP:0001931) | 2.37251499 |
| 83 | Abnormality of the pleura (HP:0002103) | 2.37174292 |
| 84 | IgA deficiency (HP:0002720) | 2.36794647 |
| 85 | Granulocytopenia (HP:0001913) | 2.35816258 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.33482384 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.33482384 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.32154311 |
| 89 | Hemoptysis (HP:0002105) | 2.30963733 |
| 90 | Hypoproteinemia (HP:0003075) | 2.28437656 |
| 91 | Hematochezia (HP:0002573) | 2.27806719 |
| 92 | Chest pain (HP:0100749) | 2.26813415 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.26390411 |
| 94 | Bronchitis (HP:0012387) | 2.26358899 |
| 95 | Pulmonary embolism (HP:0002204) | 2.23264050 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.22922318 |
| 97 | B lymphocytopenia (HP:0010976) | 2.22879725 |
| 98 | Abnormality of B cell number (HP:0010975) | 2.22879725 |
| 99 | Myocardial infarction (HP:0001658) | 2.22457877 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.20900104 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.20851818 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.20851818 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.20851818 |
| 104 | Autoimmune hemolytic anemia (HP:0001890) | 2.18147694 |
| 105 | Restrictive lung disease (HP:0002091) | 2.17676750 |
| 106 | Lymphoma (HP:0002665) | 2.17109892 |
| 107 | Gingival bleeding (HP:0000225) | 2.16291941 |
| 108 | Anorexia (HP:0002039) | 2.16265337 |
| 109 | Increased IgM level (HP:0003496) | 2.15399886 |
| 110 | Gangrene (HP:0100758) | 2.13085826 |
| 111 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12299188 |
| 112 | Urticaria (HP:0001025) | 2.12181349 |
| 113 | Keratoconjunctivitis sicca (HP:0001097) | 2.11736231 |
| 114 | Sepsis (HP:0100806) | 2.11483026 |
| 115 | Hypochromic microcytic anemia (HP:0004840) | 2.11288879 |
| 116 | Joint swelling (HP:0001386) | 2.05941053 |
| 117 | Alveolar cell carcinoma (HP:0006519) | 2.05748903 |
| 118 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.00407049 |
| 119 | Prolonged bleeding time (HP:0003010) | 1.99477507 |
| 120 | Abnormality of the renal cortex (HP:0011035) | 1.96142540 |
| 121 | Attenuation of retinal blood vessels (HP:0007843) | 1.92472270 |
| 122 | Neutropenia (HP:0001875) | 1.91703738 |
| 123 | Skin rash (HP:0000988) | 1.91505615 |
| 124 | Pulmonary fibrosis (HP:0002206) | 1.91449219 |
| 125 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.90517095 |
| 126 | Abnormality of male internal genitalia (HP:0000022) | 1.85909093 |
| 127 | Keratitis (HP:0000491) | 1.83183528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.61921464 |
| 2 | TXK | 3.50814272 |
| 3 | TYK2 | 3.14099131 |
| 4 | BLK | 2.75442964 |
| 5 | JAK3 | 2.68009581 |
| 6 | MAP3K14 | 2.61818680 |
| 7 | ZAP70 | 2.50423341 |
| 8 | TBK1 | 2.49336676 |
| 9 | KIT | 2.46218766 |
| 10 | IKBKE | 2.34681178 |
| 11 | JAK1 | 2.27994492 |
| 12 | STK10 | 2.24879191 |
| 13 | ITK | 2.22434640 |
| 14 | GRK6 | 2.10790805 |
| 15 | FRK | 2.05484373 |
| 16 | BMPR2 | 2.05211569 |
| 17 | SYK | 2.04007486 |
| 18 | IRAK4 | 2.00560932 |
| 19 | RIPK4 | 2.00293858 |
| 20 | CSF1R | 1.96797006 |
| 21 | ERN1 | 1.84341502 |
| 22 | FGFR4 | 1.83878104 |
| 23 | BTK | 1.83710189 |
| 24 | MAP3K13 | 1.79743298 |
| 25 | LCK | 1.74612197 |
| 26 | CSK | 1.74515976 |
| 27 | MAP3K10 | 1.72624119 |
| 28 | IKBKB | 1.64389629 |
| 29 | FES | 1.62534077 |
| 30 | HCK | 1.62409621 |
| 31 | IRAK3 | 1.61807862 |
| 32 | TEC | 1.52275231 |
| 33 | ADRBK2 | 1.50435801 |
| 34 | LRRK2 | 1.45083215 |
| 35 | TLK1 | 1.42749443 |
| 36 | FGFR3 | 1.36949717 |
| 37 | CAMKK2 | 1.36125727 |
| 38 | SIK2 | 1.28640680 |
| 39 | LYN | 1.28488170 |
| 40 | GRK1 | 1.22806026 |
| 41 | PKN2 | 1.22468951 |
| 42 | EEF2K | 1.21526385 |
| 43 | MARK3 | 1.15831669 |
| 44 | TRIB3 | 1.15478782 |
| 45 | ZAK | 1.14722912 |
| 46 | CDK19 | 1.14315334 |
| 47 | EPHB1 | 1.12273333 |
| 48 | TGFBR2 | 1.12187129 |
| 49 | PASK | 1.11643518 |
| 50 | TESK2 | 1.09459746 |
| 51 | CDK12 | 1.04633164 |
| 52 | MAP2K2 | 1.03665225 |
| 53 | RPS6KA4 | 1.02227973 |
| 54 | NME2 | 1.01641780 |
| 55 | CHUK | 1.01133805 |
| 56 | TAOK3 | 1.00252222 |
| 57 | PIM1 | 1.00015891 |
| 58 | JAK2 | 0.98351273 |
| 59 | PIK3CG | 0.96550102 |
| 60 | PRKCQ | 0.95900358 |
| 61 | CAMKK1 | 0.95874386 |
| 62 | CLK1 | 0.95721929 |
| 63 | MAP2K3 | 0.95516532 |
| 64 | NLK | 0.86569665 |
| 65 | KDR | 0.84967070 |
| 66 | PRKCH | 0.84597805 |
| 67 | MST4 | 0.80317909 |
| 68 | NUAK1 | 0.77338185 |
| 69 | MAP4K2 | 0.76856692 |
| 70 | TTN | 0.73067900 |
| 71 | TNK2 | 0.71613965 |
| 72 | FGR | 0.67692605 |
| 73 | ALK | 0.66891817 |
| 74 | PTK6 | 0.61714215 |
| 75 | SIK3 | 0.60273363 |
| 76 | SCYL2 | 0.59834898 |
| 77 | PRPF4B | 0.59362369 |
| 78 | MAPK7 | 0.57496619 |
| 79 | EPHA3 | 0.57050761 |
| 80 | CDK4 | 0.57049794 |
| 81 | NEK9 | 0.55879390 |
| 82 | PINK1 | 0.55723619 |
| 83 | STK4 | 0.53938684 |
| 84 | EGFR | 0.53542750 |
| 85 | ACVR1B | 0.52344715 |
| 86 | PTK2B | 0.52049277 |
| 87 | FLT3 | 0.50331402 |
| 88 | ABL1 | 0.50228661 |
| 89 | FYN | 0.49566823 |
| 90 | PDK1 | 0.48729247 |
| 91 | PRKD2 | 0.48545889 |
| 92 | WNK4 | 0.47697010 |
| 93 | OXSR1 | 0.46581826 |
| 94 | STK11 | 0.46121488 |
| 95 | GRK7 | 0.45522789 |
| 96 | CAMK1D | 0.45093637 |
| 97 | PIM2 | 0.45028552 |
| 98 | BCKDK | 0.44953755 |
| 99 | MAPK12 | 0.44815232 |
| 100 | MAP2K6 | 0.43342016 |
| 101 | NEK2 | 0.41900663 |
| 102 | MAP3K8 | 0.41593345 |
| 103 | MAPK13 | 0.41410398 |
| 104 | MAPKAPK3 | 0.40682730 |
| 105 | PRKCD | 0.38135611 |
| 106 | HIPK2 | 0.36646907 |
| 107 | CDK6 | 0.34547789 |
| 108 | BRD4 | 0.34200438 |
| 109 | ADRBK1 | 0.33972990 |
| 110 | CDK9 | 0.32964229 |
| 111 | PDGFRB | 0.32131337 |
| 112 | INSR | 0.32130804 |
| 113 | MATK | 0.32066381 |
| 114 | CAMK1G | 0.32020605 |
| 115 | BMPR1B | 0.31008544 |
| 116 | MARK2 | 0.30697104 |
| 117 | RPS6KA5 | 0.29679770 |
| 118 | MAPK11 | 0.28317509 |
| 119 | EIF2AK3 | 0.28171140 |
| 120 | MAP3K11 | 0.27851827 |
| 121 | INSRR | 0.27389612 |
| 122 | IGF1R | 0.27158314 |
| 123 | MAPKAPK2 | 0.27114238 |
| 124 | MAPK4 | 0.26520279 |
| 125 | TRPM7 | 0.25377274 |
| 126 | SIK1 | 0.25189759 |
| 127 | STK38 | 0.25171853 |
| 128 | MAP3K7 | 0.25038297 |
| 129 | RPS6KA6 | 0.23350338 |
| 130 | MAP3K3 | 0.22972628 |
| 131 | RIPK1 | 0.22776787 |
| 132 | TAOK1 | 0.20980930 |
| 133 | STK24 | 0.20065454 |
| 134 | MAPK3 | 0.19894448 |
| 135 | IRAK1 | 0.18546345 |
| 136 | SRC | 0.18405155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.91167981 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.93250808 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.93125368 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74873663 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.63422036 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57799191 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.51840666 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51348579 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.40776085 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40315140 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21611011 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13150125 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11811321 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.09885376 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93805148 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.91512258 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90734830 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.85248175 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.81405743 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.73918449 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.72850908 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.67929609 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65613562 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.64492008 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.58062741 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57039177 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.56030398 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.54541438 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53345039 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.51343624 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.48963481 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46123838 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.46030425 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43483236 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.41354359 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39698251 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.32399886 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32353238 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28730905 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27394857 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.25817327 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18091390 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.16482151 |
| 44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03454922 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.03015428 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02174615 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01361942 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.00486937 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00083858 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99328594 |
| 51 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.99311232 |
| 52 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96751749 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96479470 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.95236119 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.88547788 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88100443 |
| 57 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84490385 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.83985790 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82965490 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82667538 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82578130 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81426705 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78368976 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.77263653 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76560302 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75626944 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74033454 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73436248 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67319637 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67305186 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67086441 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.66207588 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.64254267 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62038976 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59271434 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.59157523 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58906874 |
| 78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57716752 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54564061 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53811597 |
| 81 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50819650 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49822537 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48624828 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47122180 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46815216 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.45972946 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44961791 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44565758 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43621677 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43286144 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.43217236 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41034762 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39229771 |
| 94 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39223187 |
| 95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36456872 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36377614 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35598047 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.35435872 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.34233469 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34110700 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.33957278 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33609545 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32835235 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32564570 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32325483 |
| 106 | DNA replication_Homo sapiens_hsa03030 | 0.29816902 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29595606 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.29252858 |
| 109 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28722786 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28467781 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28268941 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.27547573 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.26950866 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24496593 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24429670 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.24256295 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.24145677 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.23866700 |
| 119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23506070 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23334772 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23327153 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22408206 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21396855 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20796819 |
| 125 | Prostate cancer_Homo sapiens_hsa05215 | 0.18776002 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17467342 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13879824 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13298569 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13221552 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.06035244 |

